The Future of Cancer Care |
Tackling the Burden of a Life-Threatening Disease |
DECEMBER 14th | 9:00 a.m. EST | IN-PERSON |
|
|
In partnership with Burjeel Holdings |
As the cost of cancer is expected to soar to an astonishing $25.2 trillion globally from 2020 to 2050, the greatest financial burdens are being felt in low- and middle-income countries. While nations grapple with ways to combat the increasing weight of this troubling data, join Foreign Policy, in partnership with Burjeel Holdings to mark their 10th anniversary of their oncology conference.
Hear from medical professionals, researchers, and policy makers as we delve into the policies, medical innovations and finance models that could help alleviate the global human and economic burden of the disease. |
|
|
| Dr. Catharine Young
Head of Global Oncology, Office of Science and Technology (OSTP), The White House |
| |
|
Rep. Mike Kelly
United States Member of Congress (R-PA) |
| Juan Pablo Uribe
Global Director, Health, Nutrition & Population and the Global Financing Facility, World Bank |
|
|
Danielle Bitterman
Radiation Oncologist and AI Researcher, Brigham and Women's Hospital |
| Dr. Julie R. Gralow
Chief Medical Officer (CMO) and Executive Vice President, American Society of Clinical Oncology |
| Dr. Jason Hipp
Chair, Division of Computational Pathology and Artificial Intelligence, Mayo Clinic |
|
|
Want to receive FP newsletters? Manage your FP newsletter preferences. |
Foreign Policy is a division of Graham Holdings Company. All contents © 2023 Graham Digital Holding Company LLC. All rights reserved. Foreign Policy, 655 15th St NW, Suite 300, Washington, DC, 20005. |
|
|
|
